Fig. 70 (abstract P375).From: 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part twoPrespecified subgroup analysis of Disease-Free-Survival and Overall Survival, according to the TME immune typeBack to article page